Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²)

BD² seeks multidisciplinary teams to collaborate and explore the fundamental mechanisms, heterogeneity, progression, and underlying biology of bipolar disorder.

Apply Now

BD² is the first organization focused on funding and advancing research and care for bipolar disorder on a global scale.

Learn More

We engage people with lived experience and collect data in real-world clinical settings to advance the scientific understanding of bipolar disorder and improve care.

Learn More

We are forging research pathways to lift the ceiling on scientific understanding and to create new interventions so that everyone with bipolar disorder can thrive.

Data are shared and analyzed across genetic background, biological markers, and clinical treatment to drive discovery, reinvest in and improve care, and inspire new research questions.

100 +

Scientists and clinicians in BD²’s network who are transforming the bipolar disorder research landscape.

BD² invests in and connects prominent scientists, clinicians, and people with lived experience to deepen understanding.

$78 Million

Committed in grants to close fundamental gaps in scientific understanding of bipolar disorder.

We implement an intentionally collaborative, open science approach aiming to collapse the timeline from scientific breakthroughs to improved care.

4,000

People with lived experience who will participate in the BD² longitudinal cohort study over the next five years.

Current research, treatment, and care for bipolar disorder lacks scientific precision of the disorder and its diversity. We aim to change that.

About Bipolar Disorder

Bipolar disorder is often studied through the lens of other psychiatric conditions and receives less funding, despite affecting 3% of the global population.

It takes 7 years on average to diagnose bipolar disorder.
It takes 17 years on average to translate a scientific discovery to meaningful interventions for people with bipolar disorder.
Fewer than 50% of individuals find effective treatments.

BD² was created to provide leadership to revitalize and expand the scientific field, implement fundamental direction for research, and offer new hope for those living with bipolar disorder.

Researching previously unknown scientific foundations of bipolar disorder, including biological indicators and genetic mechanisms.
Building the largest collaborative scientific network for bipolar disorder focused on applying learnings to evidence-based, personalized treatment.
Collecting and sequencing the largest and most diverse set of brain samples to expand the understanding of the disorder.

With a collective force focused on transforming bipolar disorder research and care, we see a future where all people with bipolar disorder thrive.

A bipolar diagnosis is identifiable at the onset of proven genetic and biological markers.
Evidence-based treatments are discovered, and improved outcomes are possible for people with bipolar disorder within a short time of diagnosis.
All people with bipolar disorder manage the disorder effectively and thrive in their lives.

Our mission is to accelerate scientific understanding of bipolar disorder and advance clinical care through cross-disciplinary collaboration, data sharing, and real-time learning.

Our Work

Integrated Network

Activate a collaborative infrastructure between clinical settings and a longitudinal research study to translate real-time findings into improvements in care.

Brigham and Women's Hospital-McLean Hospital

Johns Hopkins University

Mayo Clinic

University of California, Los Angeles

University of Michigan

UTHealth Houston

Discovery Research

Improve the scientific understanding of the biological mechanisms of bipolar disorder.

Yale University

Stanford University

University of Texas Austin

Northwestern University

New York Genome Center

Rutgers University

New York University

Columbia University

KTH Royal Institute of Technology

Wyss Institute at Harvard University

Brain Omics Platform

Assess the transcriptomic, epigenetic, and proteomic characteristics of brain tissue derived from people with bipolar disorder.

Icahn School of Medicine at Mount Sinai

University of Pittsburgh

California Institute of Technology

Genetics Platform

Perform genetic sequencing on a large, diverse population of people with bipolar disorder to contribute to the genetic database.

The Broad Institute of MIT and Harvard

University of California, Los Angeles

New York Genome Center

Who We Are

Our comprehensive, hypothesis-driven approach breaks down barriers between innovation, scientific findings, and clinical care.

Explore All

October 31, 2024

Blog

Bridging Science, Care, and Hope: Highlights from the BD² Integrated Network Meeting in Chicago

Last week in Chicago, we had an energetic and productive meeting with our BD² Integrated Network…

October 31, 2024

Press Release

BD² and DBSA Partner to Improve the Lives of People Living with Bipolar Disorder

Washington, DC – BD²: Breakthrough Discoveries for thriving with Bipolar Disorder and Depression…

September 26, 2024

Press Release

BD² Expands Foundational Effort to Understand Biology of Bipolar Disorder with $36 Million in New Grants

Washington, D.C. – BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today…

September 12, 2024

Blog

Inside BD²’s Integrated Network: Coordinating Clinical & Biological Data from 4,000 Participants to Rapidly Improve Lives

When BD²’s Integrated Network set out to build its groundbreaking approach to shorten the time…

August 22, 2024

Blog

Inside BD²’s Integrated Network: How the Learning Health Network is Improving Clinical Care and Outcomes

A Learning Health Network is a relatively new, innovative concept that brings healthcare delivery…

August 7, 2024

Blog

Inside BD²’s Integrated Network: Connecting Bipolar Disorder Research with Clinical Care in Unprecedented Ways

The BD² Integrated Network is a groundbreaking approach designed to shorten the time it takes for…

BD² is invested in the talent of our people and partners, fostering team development and connection across the network.

Explore Our Team

A message from our Managing Director

"The wonder of science is that while we can’t know where new discovery will come from, we can stack the deck in our favor and aim it towards the greatest impact for people."

– Cara Altimus, PhD, Managing Director